Leveraging expertise in protein structure, medicinal chemistry, and drug development, Pcovery combines various technologies to identify, evaluate, and optimize novel antifungal compounds. Their research platform includes high throughput screenings for fungicidal activity, specificity, synergy, and resistance, as well as structural characterization of drug-target interactions. With a team of experts in anti-fungal drug development, chemistry, biochemistry, structural biology, and membrane transport, Pcovery aims to create a powerful and innovative type of anti-fungal drug. Additionally, the company is also developing cardiovascular drugs that selectively target an essential plasma membrane transport system in fungi, offering potential treatment options for both fungal infections and cardiovascular diseases.